109 related articles for article (PubMed ID: 25025147)
1. Old tracer for a new purpose: potential role for 99mTc-2-Methoxyisobutylisonitrile (99mTc-MIBI) in renal transplant care.
Dizdarevic S; Aplin M; Newport MJ; Ryan N; Holt S; Goubet S; Goldberg L; Miles KA; Peters AM
Nucl Med Commun; 2014 Oct; 35(10):1058-66. PubMed ID: 25025147
[TBL] [Abstract][Full Text] [Related]
2. Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancer.
Wong M; Evans S; Rivory LP; Hoskins JM; Mann GJ; Farlow D; Clarke CL; Balleine RL; Gurney H
Clin Pharmacol Ther; 2005 Jan; 77(1):33-42. PubMed ID: 15637529
[TBL] [Abstract][Full Text] [Related]
3. Renal and hepatic kinetics of Tc-99m-labelled hexakis-methoxy-isobutyl Isonitrile.
Dizdarevic S; Aplin M; Ryan N; Holt SG; Goldberg L; Miles KA; Peters AM
Drug Metab Lett; 2012; 6(4):242-6. PubMed ID: 23745949
[TBL] [Abstract][Full Text] [Related]
4. Relationship of hepatic functional imaging to irinotecan pharmacokinetics and genetic parameters of drug elimination.
Michael M; Thompson M; Hicks RJ; Mitchell PL; Ellis A; Milner AD; Di Iulio J; Scott AM; Gurtler V; Hoskins JM; Clarke SJ; Tebbut NC; Foo K; Jefford M; Zalcberg JR
J Clin Oncol; 2006 Sep; 24(26):4228-35. PubMed ID: 16896007
[TBL] [Abstract][Full Text] [Related]
5. Use of early postoperative MAG3 renal scan to predict long-term outcomes of renal transplants.
Park UJ; Kim HT; Cho WH; Kim MY; Hwang EA; Han SY; Park SB; Kim HC; Zeon SK
Exp Clin Transplant; 2013 Apr; 11(2):118-21. PubMed ID: 23477352
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI imaging as a predictor of therapy response in osteosarcoma compared with multidrug resistance-associated protein and P-glycoprotein expression.
Burak Z; Moretti JL; Ersoy O; Sanli U; Kantar M; Tamgac F; Basdemir G
J Nucl Med; 2003 Sep; 44(9):1394-401. PubMed ID: 12960182
[TBL] [Abstract][Full Text] [Related]
7. Assessment of P-glycoprotein in patients with malignant bone and soft-tissue tumors using technetium-99m-MIBI scintigraphy.
Taki J; Sumiya H; Asada N; Ueda Y; Tsuchiya H; Tonami N
J Nucl Med; 1998 Jul; 39(7):1179-84. PubMed ID: 9669390
[TBL] [Abstract][Full Text] [Related]
8. [The relationship between 99mTc-MIBI scintimammography of breast cancer and multidrug-resistant proteins].
Cui SD; Liu ZZ; Liu H; Li LF; Yang H; Li WL
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):606-8. PubMed ID: 16438870
[TBL] [Abstract][Full Text] [Related]
9. Technetium-99m-hexakis-2-methoxyisobutylisonitrile scintigraphy and multidrug resistance-related protein expression in human primary lung cancer.
Duan XY; Wang JS; Liu M; Guo YM
Ann Nucl Med; 2008 Jan; 22(1):49-55. PubMed ID: 18250987
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
[TBL] [Abstract][Full Text] [Related]
11. Effect of the NSAID diclofenac on 99mTc-MAG3 and 99mTc-DTPA renography.
Mustafa S; Elgazzar AH
J Nucl Med; 2013 May; 54(5):801-6. PubMed ID: 23528384
[TBL] [Abstract][Full Text] [Related]
12. (99m)Tc-mercaptoacetyl triglycine renography to monitor renal transplant function among kidneys from donors after cardiac death.
Majima T; Hattori R; Funahashi Y; Komatsu T; Kato M; Yamada S; Kamihira O; Goto M
Transplant Proc; 2012 Jan; 44(1):49-53. PubMed ID: 22310576
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-MIBI scintigraphy as a functional method for the evaluation of multidrug resistance in breast cancer patients.
Sergieva SB; Timcheva KV; Hadjiolov ND
J BUON; 2006; 11(1):61-8. PubMed ID: 17318954
[TBL] [Abstract][Full Text] [Related]
14. 99mTc-MIBI in the assessment of response to chemotherapy and detection of recurrences in bone and soft tissue tumours of the extremities.
Moustafa H; Riad R; Omar W; Zaher A; Ebied E
Q J Nucl Med; 2003 Mar; 47(1):51-7. PubMed ID: 12714955
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC.
Taylor AT; Lipowska M; Hansen L; Malveaux E; Marzilli LG
J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m methoxyisobutylisonitrile imaging for parathyroid adenoma: relationship to P-glycoprotein or multidrug resistance-related protein expression.
Kao A; Shiau YC; Tsai SC; Wang JJ; Ho ST
Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1012-5. PubMed ID: 12173014
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Value of Semiquantitative Analysis of 99mTechnetium-Methoxyisobutylisonitrile (99mTc-MIBI) Imaging in Predicting Early-Stage Cervical Lymph Node Metastasis of Thyroid Carcinoma.
Zhu XC; Zhou K; Xu SQ; Ma YB
Med Sci Monit; 2017 Mar; 23():1552-1558. PubMed ID: 28362720
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
[TBL] [Abstract][Full Text] [Related]
19. Incremental diagnostic value of preoperative 99mTc-MIBI SPECT in patients with a parathyroid adenoma.
Lorberboym M; Minski I; Macadziob S; Nikolov G; Schachter P
J Nucl Med; 2003 Jun; 44(6):904-8. PubMed ID: 12791817
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-MIBI Imaging in the presurgical characterization of thyroid follicular neoplasms: relationship to multidrug resistance protein expression.
Saggiorato E; Angusti T; Rosas R; Martinese M; Finessi M; Arecco F; Trevisiol E; Bergero N; Puligheddu B; Volante M; Podio V; Papotti M; Orlandi F
J Nucl Med; 2009 Nov; 50(11):1785-93. PubMed ID: 19837765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
